Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Change in Receivables (2016 - 2022)

Historic Change in Receivables for Aethlon Medical (AEMD) over the last 10 years, with Q4 2022 value amounting to -$114849.0.

  • Aethlon Medical's Change in Receivables changed N/A to -$114849.0 in Q4 2022 from the same period last year, while for Sep 2023 it was -$114849.0, marking a year-over-year decrease of 57096.45%. This contributed to the annual value of -$127965.0 for FY2023, which is 50598.1% down from last year.
  • As of Q4 2022, Aethlon Medical's Change in Receivables stood at -$114849.0.
  • Aethlon Medical's 5-year Change in Receivables high stood at $206729.0 for Q4 2019, and its period low was -$114849.0 during Q4 2022.
  • Moreover, its 5-year median value for Change in Receivables was -$4001.0 (2022), whereas its average is $8312.6.
  • Data for Aethlon Medical's Change in Receivables shows a peak YoY increase of 2336.99% (in 2022) and a maximum YoY decrease of 11168.76% (in 2022) over the last 5 years.
  • Aethlon Medical's Change in Receivables (Quarter) stood at $74813.0 in 2018, then skyrocketed by 176.33% to $206729.0 in 2019, then tumbled by 98.55% to $3000.0 in 2020, then tumbled by 670.53% to -$17116.0 in 2021, then plummeted by 571.0% to -$114849.0 in 2022.
  • Its last three reported values are -$114849.0 in Q4 2022, -$13116.0 for Q2 2022, and -$4001.0 during Q1 2022.